HEALTH OF WOMAN. 2019.7(143): 46–53; doi 10.15574/HW.2019.143.46

O.A. Dyndar, T.R. Nykoniuk, L.V. Manzhula, V.F. Oleshko
Bogomolets National Medical University, Ukraine

The objective: to determine the features of lactation in obese puerperas, depending on the body mass index and the therapeutic and preventive measures.

Materials and methods. The analysis and evaluation of quantitative and qualitative indicators (lactose, casein, total protein, lipids, lactoferrin, transferrin, ceruloplasmin, vitamins C and E, immunoglobulins of G, A, M classes) of maternal milk in the dynamics of the postpartum period in 386 puerperas was conducted. The main group consisted of 115 women with obesity, the management of the preconception period, pregnancy and the postpartum period was carried out according to the proposed by us program, including non-drug and drug methods. The comparison group included 103 puerperas with obesity, the management of which was carried out in accordance with the Order No. 417 of the Ministry of health of Ukraine dated 15.07.2011. The control group consisted of 53 primiparous with normal body weight.

Results. Analysis of the state of lactation revealed hypogalactia and pathological changes in the qualitative composition of breast milk, manifested in women with obesity and lower levels of lactose and lactoferrin by 1.6 times, total protein, ceruloplasmin by 2.2 times, lipids by 2.1 times, transferrin by 1.4 times, casein by 1,5 times, vitamin C by 1,8 times and E by 1,5 times, and the content of IgG by 2.1 times, IgM by 1.9 times, IgA by 2.2 times. The stage of hypogalactia severity and pathological changes in the quality of breast milk increase due to the body mass index growth.

Conclusion. The proposed pathogenetically justified program of therapeutic and preventive measures contributed to the increase in the volume of breast milk and its quality improve.

Key words: postpartum period, lactation, obesity.

REFERENCES

1. Abol’jan LV, Novikova SV. 2011. Modern aspects of breastfeeding. Pediatrija. Zhurnal im. G.N. Speranskogo 90;1: 80–83.

2. Avramenko TV, Makarenko MV, Govseev DA. 2016. Modern methods of diagnosis and correction of gestational diabetes mellitus in pregnant women (Clinical lecture). Zdorov’e zhenshhiny 3 (109):10–14.

3. Benjuk VA, Makarenko MV, Dyndar’ EA, Usevich IA, Govseev DA. 2019. Algorithms in obstetrics and gynecology. Spravochnik vracha. K, TOV «Doktor-Media»: 510.

4. Benjuk VO, Mel’nykov SM, Nykonjuk TR, Dyndar OA, Synycja JaV. 2002.  Non-drug prevention of perinatal complications. Zbirnyk naukovyh prac’ «Asociacija akusheriv-ginekologiv Ukrai’ny». Kyiv: 128–131.

5. Vasil’eva MV, Novikova AA. 2013. Study of the spread of obesity disease in the modern World. Biomedicinskaja inzhenerija i jelektronika 2:51–54.

6. Vdovichenko Ju.P, Goncharuk NP, Gurzhenko EJu. 2017. Analysis of cases of abdominal delivery in acute fetal hypoxi. Zdorov’e zhenshhiny 5 (121): 28–31.

7. Venckovskaja IB, Benjuk SV, Dyndar’ EA, Nikonjuk TR, Shherba EA. 2014. Efferent therapy of cholestatic hepatosis in pregnant women. Zbirnyk naukovyh prac’ Asociacii’ akusheriv-ginekologiv Ukrainy. K, «Poligraf pljus»: 63–66.

8. Gojda NG, Vdovichenko JuP, Moiseenko RA. 2017. The role of the Ukrainian legislature in monitoring public health programmes. Zdorov’e zhenshhiny 2 (118): 33–35.

9. Ingerlejb MB. 2014. A complete directory of research and analysis in medicine. M, Omega-L: 500.

10. Kochetov AG, Ljang OV, Masenko VP et al. 2012. Methods of statistical processing of medical data. M, RKNPK: 42.

11. Lopatkina LV. 2013. On the influence of non-drug treatments on weight loss in metabolic syndrome. Saratovskij nauchno-medicinskij zhurnal 9;4: 975–979.

12. Malanchuk LM, Kryvyc’ka GO. 2015. Dishormonal diseases of the female reproductive system – the problem of today. Aktual’ni pytannja pediatrii, akusherstva ta ginekologii 2:124–128.

13. Osipova AA, Smetnik VP. 2012. Overweight and abdominal obesity in patients with tumor and non-tumor forms of hyperprolactinemia: the effect of therapy with parlodel, norprolac and dostinex. Probl. reprodukcii 8;1:12–17.

14. Sudakova EA, Butrova SA, Goncharov NP. 2011. Features of induced and spontaneous secretion of prolactin in obese young women. Prob. jendokr. 37;6: 13–16.

15. Truhacheva NV. 2013. Mathematical statistics in biomedical research with the use of Statistica. M, GJeOTAR-Media:384.

16. Abraham S. 2013. The obesity problem. IN. Engl. J. Med. 338;16: 1158–1160.

17. Bouchard С. 2015. Genetigue et obesite chez 1’ home. Diabete Metabol. 14;4: 407–413.

18. Bjorntorp Per. Classification of obese patients and complications related to the distribution of surplus fat nutrition. 6;2:131–137. 2015.

19. Dyndar ОА, Benyuk VО, Lastoveckaya LD. 2017. Risks of miscarriage and noncarrying of pregnancy in women with excessive body weight, obesity and metabolic syndrome. Zdorov’e zhenshhiny 5 (121): 78–81.

20. Garner Peter R. 2015. The impact of obesity on reproductive function. Semin Reprod. Endocrinol. 8;1: 32–43. https://doi.org/10.1055/s-2007-1021421

21. Ogden CL, Carroll MD, Kit BK, Flegal KM. 2014. Prevalence of childhood and adult obesity in the United States. JAMA. 311: 806–814. https://doi.org/10.1001/jama.2014.732; PMid:24570244 PMCid:PMC4770258